ranQ
ranQ
ranQ
DirectoryIndustriesPlacesKnowledgeComparisonsSoon
Sign inCheck visibility
ranQHSG Startup LabelRecognised by the
HSG Startup Label

The leading AI company directory, built to boost AI visibility.

DEENFRIT
Product
  • Pricing
  • Directory
  • Industries
  • Trust Score
Company
  • About
  • Partner program
  • Contact
  • Legal
© 2026 cohaga AG · All Rights Reserved · St. Gallen, Switzerland · Imprint747,212 companies indexed · Last updated: today
DirectoryBusiness & Technical ServicesResearch instituteAllschwilCancentus GmbH
Cancentus GmbH Logo
Verified· 2 sourcesTrust Score
Summary

About the company

Cancentus GmbH develops cancer therapies that target DNA replication stress in cancer cells. Its programs include novel payloads for antibody-drug conjugates, a helicase inhibitor and drug combinations; the company also offers AI-driven compound screening and lead optimization.

AI-generated
Presence

Service area

Offering

Products & services

Industry:Research institutePharmaceutical company
LeadhubOutbound Leads by COHAGA

Looking for direct email addresses and phone numbers?

Leadhub delivers verified contact details and decision-makers from over 750,000 Swiss companies — management, procurement, marketing, HR.

Discover Leadhub
3.5/5

Cancentus GmbH

✓ Offered4
Cancer-Selective ADC Payload
A novel payload for antibody-drug conjugates that exploits DNA replication stress in cancer cells. It is being developed with a proprietary linker and assessed preclinically for activity and tumour growth inhibition.
Selective Helicase Inhibitor
A small-molecule inhibitor of a DNA helicase under development. The approach targets cancer cells with inactivated or mutated p53; identified medicinal chemistry starting points are advancing through lead optimization.
Combination Cancer Therapy
A combination of anti-cancer agents studied in preclinical mouse models for increased anti-tumour activity while sparing normal cells. Further development includes additional preclinical studies and planning for clinical trials.
AI-Driven Drug Development
In-silico library screening and lead optimization for drug discovery projects. Services include predicted binding affinities, 3D models of screened compounds, and access to project results and intellectual property.
Trust & reputation

ranQ Trust Score of Cancentus GmbH: 3.5 out of 5.0

Trust Score3.5/ 5.0

Solid

x

Data basis 54% · As of November 2026

Cancentus GmbH has no value in the Reputation area of the ranQ Trust Score because no data is available. The area carries 42% of the weighting and drops out of the calculation for this profile; it does not lower the score, only the reported data basis.
x
CriterionValueWeight
  • Review quality: No data point — the criterion is taken out of the weighting and does not lower the score.—24%
  • Review volume: No data point — the criterion is taken out of the weighting and does not lower the score.—10%
  • Review recency: No data point — the criterion is taken out of the weighting and does not lower the score.—8%
Cancentus GmbH scores 40.1 out of 100 points in the Substance area of the ranQ Trust Score. This area carries 28% of the weighting.
x
CriterionValueWeight
  • Establishment: Years since founding or brand launch, logarithmic. The maximum is reached at 15 years.0.012%
  • Company size: The headcount band, researched by ranQ or stated by the company. It is scored in steps rather than by head count, because the data only provides bands.55.07%
Cancentus GmbH scores 85.0 out of 100 points in the Identity area of the ranQ Trust Score. This area carries 22% of the weighting.
x
CriterionValueWeight
  • Verification: Official register entry (commercial register with UID or professional-body record, 55 points), confirmed domain (20 points) and confirmed ranQ profile (up to 25 points, depending on completeness).85.022%
Cancentus GmbH scores 5.1 out of 100 points in the Visibility area of the ranQ Trust Score. This area carries 8% of the weighting.
x
CriterionValueWeight
  • Website authority: Ahrefs' Domain Rating measures, on a scale of 0 to 100, how strongly a website is linked from other websites. For Swiss SMEs the range up to 40 is typical; the maximum is reached at 35.5.14%
  • Media authority: No data point — the criterion is taken out of the weighting and does not lower the score.—4%
Qualifications+0.00

Cancentus GmbH reaches a ranQ Trust Score of 3.5 out of 5.0 — rated «Solid». No public customer reviews are available for this provider; the rating is based on the remaining criteria. The data basis is 54%, so the score is backed by part of the criteria. As of November 2026.

The Trust Score cannot be bought and is calculated from publicly verifiable data.

Knowledge

No knowledge articles yet

Once Cancentus GmbH has claimed this profile, we'll publish editorial articles and case studies here together.

Get started
Comparisons

Cancentus GmbH in comparison

Soon

Industry comparisons are coming soon

We're preparing industry comparisons that rank Cancentus GmbH by reviews, experience and specialisations.

Is this your company?

Claim the company profile of Cancentus GmbH to make its contact details visible. With a plan we additionally create and publish industry comparisons, articles and much more.

Secure profile

Location

Hegenheimermattweg 167a
4123 Allschwil

At a glance

Legal form
Limited Liability Company
UID
CHE-493.779.873
Founded
2026 · 0 years
Last commercial register change
January 23, 2026
Employees
1 to 10

Active in 1 of 26 cantons

  • BLBasel-Country
Legal form: Graded by liability and disclosure. The weight is kept small: a sole proprietorship is not a dubious company, it is just liable differently.
88.0
6%
  • Branch offices: Branch offices linked in the commercial register. Having none is normal and costs no points.70.03%
    • Full methodology

    Similar companies

    GG
    Gubra GmbH
    Allschwil
    MG
    MiHKAL GmbH
    Allschwil
    BA
    BIIE AI Initiative AG
    Allschwil
    SB
    Swiss Biome Institute GmbH
    Allschwil
    AP
    Actelion Pharmaceuticals Ltd
    Allschwil
    FG
    famoser GmbH
    Allschwil
    VF
    Verein für Krebsforschung
    Arlesheim
    BA
    Biolytix AG
    Dittingen